Development of metachronous or recurrent lesion in the remnant pancreas after partial pancreatectomy for pancreatic ductal adenocarcinoma

Pancreatology ◽  
2016 ◽  
Vol 16 (4) ◽  
pp. S45
Author(s):  
Yoshitaka Gotoh ◽  
Takao Ohtsuka ◽  
Yohei Nakama ◽  
Kenjiro Date ◽  
Takaaki Fujimoto ◽  
...  
Pancreatology ◽  
2016 ◽  
Vol 16 (6) ◽  
pp. 1124-1128 ◽  
Author(s):  
Yanming Zhou ◽  
Ailing Song ◽  
Lupeng Wu ◽  
Xiaoying Si ◽  
Yumin Li

2011 ◽  
Vol 2011 ◽  
pp. 1-6 ◽  
Author(s):  
Kazuo Inui ◽  
Junji Yoshino ◽  
Hironao Miyoshi ◽  
Takashi Kobayashi ◽  
Satoshi Yamamoto

We retrospectively investigated the incidence of pancreatic ductal adenocarcinoma among patients with intraductal papillary mucinous neoplasms of the pancreas. Based on imaging in 195 such patients, we chose surgery as initial treatment for 54, and periodic evaluation over 6 to 192 months (mean, 52) for 141. In 6 of the 141 patients observed for intraductal papillary mucinous neoplasm (4.2%), pancreatic ductal adenocarcinoma developed. Further, careful monitoring for cancer occurrence in the remnant pancreas proved essential in the surgical resection group; 2 of 26 patients (7.7%) subsequently developed pancreatic ductal adenocarcinoma in the remnant pancreas, at 41 months and 137 months after surgery. Serial observation of patients with intraductal papillary mucinous neoplasms by contrast-enhanced computed tomography or magnetic resonance cholangiopancreatography therefore is critical, whether or not surgical treatment initially was performed.


2000 ◽  
Vol 15 (11) ◽  
pp. 1333-1338 ◽  
Author(s):  
Koji Uno ◽  
Takeshi Azuma ◽  
Masatsugu Nakajima ◽  
Kenjiro Yasuda ◽  
Takanobu Hayakumo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document